23 May 2013
Keywords: new, data, xoma/genentech, raptiva, positive, been, presented
Article | 04 August 2003
Positive new data have been presented for Raptiva (efalizumab) at the American Academy of Dermatology meeting in Chicago, showing its ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.